How Samsung Bioepis Is Laying A Path For Ophthalmic Biosimilars
Strategy Head Josh Lee Also Emphasizes Need For Biosimilar Education And Incentives
• By David Wallace
Josh Lee talks about how Samsung Bioepis is preparing to break into the ophthalmology market • Source: Samsung Bioepis 
